Nuclear Radiology: Page 77

Philips partners with Dutch university
By AuntMinnieEurope.com staff writers
Philips Healthcare will collaborate with VU University Medical Center in Amsterdam, Netherlands, to jointly research new multimodality imaging technologies.
February 21, 2010
Covidien signs deal to produce Mo-99 at Polish reactor
By Wayne Forrest
Healthcare technology firm Covidien has inked an agreement with the Institute of Atomic Energy in Poland to augment Covidien's supply of molybdenum-99 (Mo-99), which is used in the production of the medical isotope technetium-99m.
February 16, 2010
PET/CT cost-effective for head, neck squamous cell carcinoma
By Wayne Forrest
FDG-PET/CT is not only most effective for pretreatment screening of distant metastases in patients with head and neck squamous cell carcinoma, the combined modalities do so with no additional costs to healthcare providers, according to researchers in the Netherlands.
February 16, 2010
PET scan can increase accuracy of head/neck cancer staging
By Reuters Health
NEW YORK (Reuters Health), Feb 11 - Squamous cell carcinoma of the head and neck can be staged more accurately with whole-body PET using F-18 FDG, according to European researchers.
February 10, 2010
Reuterslogo
Study to compare 320-row CT perfusion against SPECT
By Eric Barnes
Following up on the CORE 64 study that tested the value of coronary CT angiography vis-à-vis angiography, researchers have launched a new international trial to compare 320-detector-row CT perfusion to SPECT myocardial perfusion imaging for detecting early coronary artery disease.
February 9, 2010
NRG to select new Pallas developer
By AuntMinnieEurope.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) is looking for another company to develop its 80-megawatt Pallas nuclear reactor in Petten, Netherlands.
February 1, 2010
Siemens orders PET/CT transport system
By AuntMinnieEurope.com staff writers
Siemens Healthcare has ordered the Dignity Carrier patient transportation system from LinkMed.
February 1, 2010
Report: NRG looking for new Pallas builder
By AuntMinnieEurope.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) may put its proposed 80-megawatt nuclear research reactor back out to bid after reportedly breaking off negotiations with its first choice to build the facility.
January 31, 2010
European nuke med market could triple
By AuntMinnieEurope.com staff writers
A new study from U.K. market research firm GlobalData predicts the nuclear imaging equipment market in Europe could reach $1.4 billion by 2015.
January 24, 2010
DOPA-PET/CT can alter therapy for neuroendocrine tumors
By Wayne Forrest
Swiss researchers have found that combined fluorine-18 dihydroxyphenylalanine (F-18 DOPA) contrast-enhanced PET/CT is "significantly superior" to DOPA-PET and contrast-enhanced CT in detecting neuroendocrine tumors.
January 14, 2010
2010 01 08 16 42 44 797 Veit Papillary Carcinoma Thumb
NRG schedules Petten reactor repairs
By AuntMinnieEurope.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) will begin repairs to the primary cooling water pipework of its High Flux Reactor on February 19, 2010.
December 14, 2009
NRG endorses Petten site for reactor
By AuntMinnieEurope.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) has expressed its preference for Petten, Netherlands, as the site of its proposed research reactor.
December 7, 2009
Previous Page
Page 77 of 90
Next Page